Literature DB >> 28350903

Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.

Ephraim L Tsalik1,2, Elizabeth Petzold1, Barry N Kreiswirth3, Robert A Bonomo4,5, Ritu Banerjee6, Ebbing Lautenbach7, Scott R Evans8, Kimberly E Hanson9, Jeffrey D Klausner10, Robin Patel11.   

Abstract

Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, we provide an overview of that development, highlighting several examples where innovation in study design, content, and execution is advancing the field of infectious diseases diagnostics.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibacterial resistance; devices.; diagnostics

Mesh:

Substances:

Year:  2017        PMID: 28350903      PMCID: PMC5848376          DOI: 10.1093/cid/ciw831

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

1.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

2.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.

Authors:  Karri A Bauer; Jessica E West; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kurt B Stevenson; Debra A Goff
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

Review 3.  Antibiotic resistance: the perfect storm.

Authors:  I M Gould
Journal:  Int J Antimicrob Agents       Date:  2009-08       Impact factor: 5.283

4.  Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.

Authors:  Claudia Manca; Carol Hill; Andrea M Hujer; Robin Patel; Scott R Evans; Robert A Bonomo; Barry N Kreiswirth
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 5.  Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.

Authors:  Heather R Cross; Anthony Harris; Rebekka M Arias; Henry F Chip Chambers; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

6.  MASTERMIND: Bringing Microbial Diagnostics to the Clinic.

Authors:  Robin Patel; Ephraim L Tsalik; Elizabeth Petzold; Vance G Fowler; Jeffrey D Klausner; Scott Evans
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

Review 7.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Authors:  Philipp Schuetz; Beat Müller; Mirjam Christ-Crain; Daiana Stolz; Michael Tamm; Lila Bouadma; Charles E Luyt; Michel Wolff; Jean Chastre; Florence Tubach; Kristina B Kristoffersen; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Long Wei; Neera Bhatnagar; Heiner C Bucher; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

8.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

9.  Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs.

Authors:  Katherine K Perez; Randall J Olsen; William L Musick; Patricia L Cernoch; James R Davis; Geoffrey A Land; Leif E Peterson; James M Musser
Journal:  Arch Pathol Lab Med       Date:  2012-12-06       Impact factor: 5.534

10.  Outpatient antibiotic prescribing in the United States: 2000 to 2010.

Authors:  Grace C Lee; Kelly R Reveles; Russell T Attridge; Kenneth A Lawson; Ishak A Mansi; James S Lewis; Christopher R Frei
Journal:  BMC Med       Date:  2014-06-11       Impact factor: 8.775

View more
  9 in total

1.  The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.

Authors:  Henry F Chip Chambers; Heather R Cross; Scott R Evans; Barry N Kreiswirth; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

2.  Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.

Authors:  Claudia Manca; Carol Hill; Andrea M Hujer; Robin Patel; Scott R Evans; Robert A Bonomo; Barry N Kreiswirth
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 3.  The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.

Authors:  Deverick J Anderson; Timothy C Jenkins; Scott R Evans; Anthony D Harris; Robert A Weinstein; Pranita D Tamma; Jennifer H Han; Ritu Banerjee; Robin Patel; Theoklis Zaoutis; Ebbing Lautenbach
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

4.  Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.

Authors:  Joseph D Lutgring; Cassiana Bittencourt; Erin McElvania TeKippe; Dominick Cavuoti; Rita Hollaway; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

5.  Optimizing peptide nucleic acid probes for hybridization-based detection and identification of bacterial pathogens.

Authors:  Kathleen E Mach; Aniruddha M Kaushik; Kuangwen Hsieh; Pak Kin Wong; Tza-Huei Wang; Joseph C Liao
Journal:  Analyst       Date:  2019-02-25       Impact factor: 4.616

6.  Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.

Authors:  Jacqueline Huvane; Lauren Komarow; Carol Hill; Thuy Tien T Tran; Carol Pereira; Susan L Rosenkranz; Matt Finnemeyer; Michelle Earley; Hongyu Jeanne Jiang; Rui Wang; Judith Lok; Scott R Evans
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

7.  Emerging Microtechnologies and Automated Systems for Rapid Bacterial Identification and Antibiotic Susceptibility Testing.

Authors:  Yiyan Li; Xing Yang; Weian Zhao
Journal:  SLAS Technol       Date:  2017-08-29       Impact factor: 3.047

8.  Biographical Feature: Robin Patel, M.D.(C.M.), D(ABMM), F(AAM), FIDSA, FACP.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 9.  Antimicrobial resistance among GLASS pathogens in Morocco: an epidemiological scoping review.

Authors:  Chakib Nejjari; Youness El Achhab; Amina Benaouda; Chakib Abdelfattah
Journal:  BMC Infect Dis       Date:  2022-05-07       Impact factor: 3.667

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.